| 发明名称 |
NOVEL COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS |
| 摘要 |
A corrector agent capable of stabilizing a newly synthesized cystic fibrosis transmembrane conductance regulator (CFTR) protein, useful in the treatment of cystic fibrosis. |
| 申请公布号 |
US2017100386(A1) |
申请公布日期 |
2017.04.13 |
| 申请号 |
US201615288400 |
申请日期 |
2016.10.07 |
| 申请人 |
AbbVie S.à.r.l. ;Galapagos NV |
发明人 |
Akkari Rhalid;Alvey Luke Jonathan;Bock Xavier Marie;Brown Brian S.;Claes Pieter Isabelle Roger;Cowart Marlon D.;Conrath Katja E.;Cyr Douglas;De Lemos Elsa;De Wilde Gert Jules Hector;Desroy Nicolas;Duthion Béranger;Gfesser Gregory A.;Gosmini Romain Luc Marie;Housseman Christopher Gaëtan;Jansen Koen Karel;Ji Jianguo;Kym Philip R.;Lefrancois Jean-Michel;Mammoliti Oscar;Menet Christel Jeanne Marie;Merayo Nuria Merayo;Newsome Gregory John Robert;Palisse Adeline Marie Elise;Patel Sachin V.;Pizzonero Mathieu Rafaël;Shrestha Anurupa;Swift Elizabeth C.;Tse Chris;Van der Plas Steven Emiel;Wang Xueqing |
| 分类号 |
A61K31/4545;G01N33/50;A61K45/06 |
主分类号 |
A61K31/4545 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A corrector agent for the treatment of Cystic Fibrosis, wherein the corrector agent is capable of stabilizing a newly synthesized Cystic fibrosis transmembrane conductance regulator (CFTR) protein. |
| 地址 |
Luxembourg LU |
